Medication info
Rosuvastatin Calcium 10mg Tablet

Rosuvastatin Calcium 10mg Tablet

Prescription medicationTablet
Ingredient · strength
Rosuvastatin Calcium›10.4mg / 1 tablet
Manufacturer / importer
KIMS Pharmaceutical Co., Ltd.
Appearance
Pink round film-coated tablet
Packaging
28 tablets per box [28 tablets (14 tablets/PTP x 2)]
Approval status
Active

MFDS item code 201901569 · Approved 2019.03.14 · Insurance code 059600290

Summary

Main use
Treatment of dyslipidemia, reduction of cardiovascular risk, and inhibition of atherosclerosis progression
Who uses it
Adults · Children
Adult dosage
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Before and during treatment with this medication, patients should follow a standard cholesterol-lowering diet and continue it throughout the treatment period. This medication may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is required, the dose may be adjusted to a maintenance dose. The maintenance dose is 10 milligrams once daily, which controls the condition in most patients. The maintenance dose should be adjusted appropriately at intervals of 4 weeks or more according to LDL cholesterol levels, treatment goals, and patient response; it may be increased to a maximum of 20 milligrams daily. 3. Older adults: No dose adjustment is required. 4. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Particular caution is required when administering 20mg of this medication to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score above 9. Do not administer this medication to patients with active liver disease. 6. Ethnicity: Since systemic exposure to this medication is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose of this medication is contraindicated in some of these patients.
Children's dosage
Aged 10 years to 17 years: The usual dose range is 5 milligrams to 20 milligrams once daily. (There are no clinical data on doses higher than 20 milligrams in pediatric patients.) Adjust the dose individually according to the recommended treatment goal for each patient. Adjust the dose at intervals of 4 weeks or more. Under 10 years of age: Safety and efficacy in children have not been established.

Ingredients

Manufacturer
KIMS Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of dyslipidemia, reduction of cardiovascular risk, and inhibition of atherosclerosis progression

  • Hypercholesterolemia
  • familial hypercholesterolemia
  • mixed hyperlipidemia
  • dysbetalipoproteinemia
  • increased high-sensitivity C-reactive protein
  • hypertension
  • low HDL cholesterol levels
  • smoking
  • family history of early coronary heart disease
View approved original text

This medication is used as an adjunct when diet and exercise do not adequately control primary hypercholesterolemia and mixed hyperlipidemia patients. It also helps lower cholesterol levels in patients with homozygous familial hypercholesterolemia or pediatric patients aged 10 to 17 years with heterozygous familial hypercholesterolemia. It lowers total cholesterol and LDL-cholesterol levels to goal levels, delaying the progression of atherosclerosis. It can also be used as an adjunct to dietary control in patients with primary dysbetalipoproteinemia. Additionally, it reduces the risk of stroke, myocardial infarction, and arterial revascularization in men over 50 and women over 60 with elevated high-sensitivity C-reactive protein levels and additional cardiovascular disease risk factors. Thus, this medication is used to improve cholesterol levels and reduce the risk of cardiovascular disease.

Dosage and Administration

Adult dosage

1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Before and during treatment with this medication, patients should follow a standard cholesterol-lowering diet and continue it throughout the treatment period. This medication may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is required, the dose may be adjusted to a maintenance dose. The maintenance dose is 10 milligrams once daily, which controls the condition in most patients. The maintenance dose should be adjusted appropriately at intervals of 4 weeks or more according to LDL cholesterol levels, treatment goals, and patient response; it may be increased to a maximum of 20 milligrams daily. 3. Older adults: No dose adjustment is required. 4. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Particular caution is required when administering 20mg of this medication to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score above 9. Do not administer this medication to patients with active liver disease. 6. Ethnicity: Since systemic exposure to this medication is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose of this medication is contraindicated in some of these patients.

Children's dosage

Aged 10 years to 17 years: The usual dose range is 5 milligrams to 20 milligrams once daily. (There are no clinical data on doses higher than 20 milligrams in pediatric patients.) Adjust the dose individually according to the recommended treatment goal for each patient. Adjust the dose at intervals of 4 weeks or more. Under 10 years of age: Safety and efficacy in children have not been established.

Precautions

This medication should not be used in certain patients. For example, individuals who are allergic to any ingredient of this medication, those with severe liver dysfunction, or those with muscle diseases should not take this medication. Furthermore, individuals with severely impaired renal function, pregnant or nursing women, and fertile women who are not using adequate contraception should also avoid this medication. This medication contains lactose, making it unsuitable for those with lactose intolerance or certain genetic metabolic disorders. This medication may affect liver function, so individuals who consume large amounts of alcohol or have a history of liver disease should have liver function tests before use and exercise caution. Muscle-related side effects like myalgia or myopathy may occur, thus any symptoms such as muscle pain, weakness, or cramps should be reported to a doctor immediately. Precautions are especially necessary for those with compromised renal function, hypothyroidism, a history of muscle diseases, or the elderly. This medication can rarely cause serious skin reactions or liver damage; if any symptoms such as skin rash, jaundice, or severe fatigue occur, the medication should be stopped immediately and medical advice should be sought. This medication may interact with other drugs, so if you are taking other medications, you must inform your doctor or pharmacist. Specifically, the risk of muscle side effects may be increased when used in conjunction with certain antivirals, immunosuppressants, antifungals, some antibiotics, or fibrates. Women who are pregnant or planning a pregnancy should not take this medication, and if pregnancy occurs while taking it, it should be stopped immediately. Nursing women are also advised to avoid this medication. In case of overdose, there is no specific antidote, so treatment should be symptomatic, and liver function and muscle enzyme levels should be monitored regularly. Caution should be exercised when driving or operating machinery, as dizziness may occur. This medication can be used in children and adolescents, but limited information is available regarding its effects on growth and secondary sexual characteristics, so it should be used with caution.

Side effects

Allergic reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, urticaria, myalgia, myopathy, rhabdomyolysis, asthenia, polyneuropathy, amnesia, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, ocular myasthenia, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, lichenoid drug eruption, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal hepatic failure, cognitive impairment, increased ALT, chest pain, muscle cramps, gout, erectile dysfunction, numbness, sensory abnormalities, chest discomfort, loss of appetite, abdominal distension, abnormal liver function tests, syncope, generalized pain

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be kept in a tightly closed container to avoid exposure to air or moisture, and it is best stored at room temperature between 1 degree and 30 degrees Celsius. Proper storage will help maintain the effectiveness of the medication.

Appearance and packaging

Appearance

Pink round film-coated tablet

Package unit

28 tablets per box [28 tablets (14 tablets/PTP x 2)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.